Print Digg


Lipoic Acid: Beyond ARED2 Study

Friday, March 03, 2006

Long term epidemiological studies suggest oxidative stress from environmental factors like smoking and sunlight exposure, as well as low dietary intake of antioxidants, to be the major contributing factors in the development of age related macular degeneration (AMD). Recent evidence suggests the retinal pigment epithelium (RPE) mitochondria to be the important cellular target of this oxidative stress.

The RPE mitochondria undergoes oxidative stress because it's one of the most metabolically active parts of the body, and because it experiences exposure to sunlight, and because it contains a large amount of polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA), which makes it extremely susceptible to oxidation-induced chain reaction lipid peroxidation.

Additionally, peer-reviewed studies also suggest a significant increase in the total iron level in AMD-affected maculas compared to healthy maculas. Oxidative cell death in the presence of iron involves Fenton-type reactions, which cause severe reactive oxygen species (ROS) damage to the lysosomal membranes that protect mitochondria DNA and RNA.

Lipoic acid has been suggested in a number of studies to protect RPE cells against oxidative damage by increasing and recycling cellular glutathione, the body's master antioxidant. As the references below suggest, lipoic acid may very well be the major candidate in preventing the slow visual impairment caused by AMD. This is because its antioxidant effects could be therapeutically effective on multiple mechanisms in the cytosol and mitochondria and in all the cell types in and around the macula.

FYI: Lipoic acid is a naturally occurring compound that functions as a critical cofactor in several important enzymes related to mitochondrial energy metabolism. It plays an important role in the synergism of antioxidants because it recycles and extends the metabolic lifespans of vitamin C, glutathione, and coenzyme Q10. Lester Packer, PhD, the esteemed UC Berkeley molecular and cell biology professor, as well as the the founding editor of the peer-reviewed scientific journal, Free Radical Biology and Medicine, describes lipoic acid as the "universal antioxidant" because it neutralizes free radicals in both the lipid (fatty) and watery regions of cells, in contrast to vitamin C (which is water soluble) and vitamin E (which is fat soluble).

Ellen Troyer, MT MA - Biosyntrx Chief Research Officer


Two questions: Given (1) the large amount of peer-reviewed lipoic acid science published in ophthalmology, molecular biology, and biochemistry's most prestigious journals, and (2) the year 2030 projected number of new cases of AMD, why wasn't the safe and inexpensive power-house antioxidant, alpha-lipoic acid included as part of the second National Eye Institute (NEI) Age Related Eye Disease (ARED) research study? We suggest that it is not in the best interest of the AMD at-risk public to wait for 15 years for "AREDs3" before eye care professionals recommend lipoic acid supplementation as part of a full spectrum daily multiple for AMD patients.


Clinical references available in the Biosyntrx office.